Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ceapro Inc (OP: CRPOF )

0.3332 UNCHANGED
Streaming Delayed Price Updated: 12:38 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3332
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3332
Today's Range 0.3332 - 0.3332
52wk Range 0.3169 - 0.6096
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases
From Ceapro Inc.
Via GlobeNewswire

Performance

YTD
-24.99%
-24.99%
1 Month
-24.60%
-24.60%
3 Month
-35.65%
-35.65%
6 Month
-34.99%
-34.99%
1 Year
-35.44%
-35.44%

More News

Read More
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
From Ceapro Inc.
Via GlobeNewswire
Ceapro Announces Data from Research Collaboration with McMaster University to be Presented at the 2023 American Thoracic Society (ATS) International Conference
From Ceapro Inc.
Via GlobeNewswire
Ceapro Announces Data from Research Collaboration with the Angiogenesis Foundation to be Presented at the 2023 Annual Meeting of the Wound Healing American Society
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Recognized as a Top 50 TSX Venture Exchange Company
From Ceapro Inc.
Via GlobeNewswire
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event
From Ceapro Inc.
Via GlobeNewswire
Ceapro Announces Grant of Stock Options
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Reports 2022 Third Quarter and Nine-Month Financial Results and Operational Highlights
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Launches Next Phase of Scale Up for its Disruptive PGX Technology to Pursue Product Development for Nutraceutical and Pharmaceutical Markets
From Ceapro Inc.
Via GlobeNewswire
Ceapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed Carriers
From Ceapro Inc.
Via GlobeNewswire
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
From JTC Team, LLC
Via AccessWire
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
From JTC Team, LLC
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.